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Objective: Schizophrenia is associated with a marked reduction in reproductive success, yet 
alleles that are common contribute substantially to its liability. Among several possible 
explanations for this, it has been postulated that those who carry risk alleles but are 
unaffected are at some reproductive advantage, offsetting the effects of negative selection 
in those who are affected. Here, we sought to test this, isolating the effects of risk alleles on 
fecundity from those effects that are contingent on expressing the disorder.  
Method: We compared the burden of schizophrenia risk alleles, as indexed by a polygenic risk 
score (PRS), carried by 139,679 participants in the UK Biobank study who did not have 
schizophrenia, with the number of offspring of those individuals.  
Results: Higher schizophrenia liability in subjects without manifest disorder was weakly but 
significantly associated with having more children (B=0.006, 95%CI=[0.002, 0.010], p=0.002). 
The relationship was dependent on gender, with a positive correlation between number of 
children and liability in females (B=0.011, 95%CI=[0.006, 0.016], p=7.1x10-5) whereas in males, 
higher liability was associated with being childless (OR=0.96, 95%CI=[0.94, 0.98], p=7.8x10-5).  
We also present data showing that the negative effect on number of children associated with 
schizophrenia itself is 2 to 15-fold greater than the positive effect associated with PRS in 
unaffected individuals.  
Conclusions: We propose that this complex relationship between liability and fecundity is 
consistent with sexual selection.  While the overall pattern of a weak positive correlation with 
liability may contribute to the persistence of schizophrenia risk alleles, our findings indicate 
that the negative selection acting on individuals affected by the disorder in the general 






Due to improvements in medical care and the reduction in prenatal, infant and child mortality 
in developed countries, the number of offspring can be considered a measure of an 
individual’s reproductive fitness 1. A number of studies have reported that people with 
schizophrenia, particularly males, have substantially fewer children than the general 
population 2-4. The relationship between an individual and the number of their offspring is, 
however, a complex phenotype. In addition to variance in aspects of fundamental biology 
related to fertility and foetal survival, number of offspring is also driven by the mating choices 
and opportunities of i di iduals, efle ti g that i di idual’s so ial, ultu al, eligious, 
economic and historical environment; it is unclear which of these is primarily responsible for 
the association between schizophrenia and low fecundity.  
 
Schizophrenia has a substantial heritability 5, 6 to which alleles across the frequency spectrum 
contribute 7-9. As expected for a disorder associated with low fecundity, alleles that contribute 
large effects on risk are rare, their frequencies being dictated by the balance between the 
rates of new (de novo) mutation formation and of removal of those mutations by strong 
negative selection, which typically occurs within a few generations 10. However, a substantial 
component of liability to schizophrenia is conferred by risk alleles that are common and which 
individually confer small effects on risk 11, 12. There has been a long-standing debate, from an 
evolutionary perspective, as to how common risk alleles persist in the population 13: 
hypotheses that have been proposed include; schizophrenia alleles confer reproductive 
advantages in unaffected people depending on their particular genetic background or 
environmental context (historical or contemporary); risk alleles are maintained by linkage to 
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positively selected alleles; common risk alleles for schizophrenia are individually too weak to 
be effectively purged by negative selection;  risk alleles occur in regions where the effects of 
more deleterious variants cause haplotypes to be removed from the gene pool, which reduces 
genetic diversity, impairs the efficiency of selection, and allows allowing alleles with small 
deleterious effects to rise in frequency by drift 13.  Of these possible explanations, perhaps 
the most widely known is the notion that schizophrenia may persist in modern populations 
because those carrying risk alleles but who do not manifest schizophrenia have psychological 
traits that increase their fecundity. For example Jarvik and Deckard 14  proposed that schizoid-
paranoid personality traits found in non-psychotic relatives of those with schizophrenia, 
hi h they te ed the Odyssea  pe so ality, ay e ad a tageous i  a o ld plagued y 
te o , st ife a d a . 
 
A recent study on reproductive fitness and genetic risk of psychiatric disorders in 93,720 
genotyped Icelanders (aged at least 45 years, without a diagnosis of a psychiatric disorder)15  
found no evidence that common schizophrenia risk alleles confer reproductive advantage, 
although, as expected, rare alleles with large effects sizes in the form of copy number variants 
(CNVs) did confer reproductive disadvantage, with a greater fecundity reduction in males than 
females.  
 
Here, we sought to examine the relationship between schizophrenia liability and fecundity in 
the UK Biobank 16, a powerful resource for testing hypotheses at population level. Specifically, 
we sought to test the hypothesis that the burden of common risk alleles for schizophrenia is 
associated with reproductive advantage/disadvantage in subjects without schizophrenia. 
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Given sex related effects of the disorder on fecundity, we also tested male and female risk 
allele carriers separately.  
 
Methods 
UK Biobank data 
UK Biobank is a large prospective cohort of more than half a million residents of the UK for 
which genetic data and number of children data are available. The phe otype u e  of 
children  is the self-report response to Ho  a y hild e  ha e you fathe ed (or 
othe ed ?  If the a s e  as >  the  it was discounted by the UK Biobank; if the 
a s e  > 5  the  the pa ti ipa t as asked to o fi  the answer.   
 
The schizophrenia GWAS we used to define risk alleles was primarily of European Ancestry so 
we restricted the sample to those who self-reported as being of white UK or Irish ancestry 
(N=140,494). In the first wave of UKBB data, 227 people (79 males and 148 females) have self-
declared schizophrenia or been admitted to hospital for an episode of schizophrenia or 
schizoaffective disorder. These people were removed as we were interested in people not 
expressing the disorder. We also excluded 558 people with missing information on the 
numbers of children and thus 139,679 were included in our analyses. 
 
UK Biobank obtained informed consent from all participants and this study was conducted 
under generic approval from the NHS National Research Ethics Service (approval letter dated 
13 May 2016, Ref 16/NW/0274) and under UK Biobank approvals for application #14421. 
 
Measuring Burden of Risk Alleles:  Polygenic Risk Scores (PRS) 
6 
 
To define risk alleles, we used the largest available schizophrenia GWAS comprising a meta-
analysis of two large studies 1) the latest study of the Psychiatric Genetic consortium (PGC2) 
8 and 2) the latest study on individuals with a clinical diagnosis of schizophrenia attending a 
clozapine clinic and controls (CLOZUK) 13. The schizophrenia datasets were imputed using 
SHAPEIT/IMPUTE2 software 17, 18 with a combination of the 1000 Genomes phase 3 (1KGPp3) 
and UK10K datasets as a reference panel. The total number of subjects in the data included 
40,675 schizophrenia cases and 64,643 controls 13. For constructing PRS in the UK Biobank, 
we included autosomal imputed genetic data that passed stringent quality control criteria 
i o  allele f e ue ies MAF  ≥ .  a d i putatio  uality s o e g eate  tha  o  e ual to 
0.9. This resulted in 5,471,613 SNPs. Using the UK Biobank genotypes, we performed clumped 
pruning using parameters r2=0.2, a physical distance threshold for clumping SNPs of 1Mb and 
an association p-value threshold in the PGC2+CLOZUK GWAS study of 0.05. The clumped 
pruning process retains SNPs that are the most significantly associated with schizophrenia 
while excluding SNPs at which the genotypes are correlated with the selected SNPs.  
 
We selected markers, based upon the schizophrenia association significance threshold 
p<0.05, to construct a polygenic score in the UK Biobank data (N markers= 32,576).  P<0.05 is 
the threshold that maximally captures polygenic risk in current studies of schizophrenia 8. The 
PRS was calculated from the effect size-weighted sum of associated alleles within each 
subject. PRS were adjusted for array (the UK Biobank used two different arrays) and the first 
8 principal components and then standardised by subtracting the population mean for PRS 
and dividing by the standard deviation. The first 8 principal components, out of 15 available 
in the Biobank, were selected after visual inspection of each pair of PCs, taking forward only 





We used Poisson regression analysis to test number of children for association with 
schizophrenia PRS, covarying for age and sex. (Age was strongly positively associated with the 
number of children in all analyses.) We examined interaction between sex and schizophrenia 
PRS comparing two Poisson regression models 1) PRS , age and sex  and 2) PRS, age, sex  and 
interaction PRS x sex.  As the distributions of numbers of children born to males and females 
may differ 15, we also performed this analysis for males and females separately.   
 
As a test of non-linear effects, we tested seven groups according to the numbers of children 
(0, 1, 2, …, 6+), and performed logistic regression analysis (adjusted for PCs, array, age as 
before), testing whether childless participants had greater or lower genetic liability to 
schizophrenia compared with participants with a particular number of children. We used the 
truncated by 6 children measure for the interaction analysis as the number of UK Biobank 
participants reporting more than 6 children is small (N=288) and the inclusion of multiple 
small groups may adversely affect with small numbers the robustness of the analyses. 
We report B-coefficients for Poisson regression analyses and odds ratios 
(OR=exponential(B))  for the logistic regression analyses. 
 
In order to compare the effect on fecundity of the PRS in individuals unaffected by 
schizophrenia with the effects seen in those with schizophrenia, e used Fishe ’s 
Fundamental Theorem of Natural Selection 20, 21, which establishes a relationship between 
fecundity and strength of selective pressure, based on additive genetic variance. The set of 
calculations we performed is detailed in the Supplementary Note. Briefly, we retrieved data 
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from GWAS and epidemiological studies, and used them to calculate the variance in fecundity 
in the general population (including those with schizophrenia) explained by the PRS. Then, we 
compared that value with the variance in fecundity that, according to our data, could be 
explained by the PRS in unaffected individuals.  The ratio of both variances allowed us to 
compare the strength of selective pressures (i.e. negative selection in affected individuals vs. 
positive selection in unaffected individuals), and infer their effect in the general population. 
 
Results 
PRS and number of children 
For males and females  (without a diagnosis of schizophrenia) combined, the number of 
children was weakly but significantly positively associated with schizophrenia PRS (B=0.006, 
95%CI=[0.002,0.010],  p=0.0017), see summary in Table 1. The effect size was very similar to 
the one reported previously in the Icelandic population 15 (B=0.006, p=0.160), although in that 
study, the association was not statistically significant. The quadratic test for non-linear 
relationships was not significant. 
 
Fecundity effects in healthy and affected individuals 
The observed positive association between schizophrenia PRS and fecundity applies to the 
subset of the general population which is unaffected by schizophrenia. When this effect is 
extrapolated to the general population, it can be compared with the known negative 
association between fecundity and onset of schizophrenia2-4. After both effects are 
considered, in the light of the schizophrenia population prevalence, the negative effect 
contributed by the disorder to the population is substantially (2 to 15-fold (95%CI)) greater 




PRS and number of children in males and females separately  
The percentages of males and females with each category of number of children born to 
males and females are shown in Figure 1.  Polygenic risk of schizophrenia was not associated 
with the number of offspring for males (B=0.001, 95%CI=[-0.005,0.007], p=0.745) but it was 
positively associated with that for females, (B=0.011, 95%CI=[0.006, 0.016], p=7.1x10-5), see 
also Table 1. 
 
We further explored the patterns of association in males and females, comparing the PRS in 
people with specific numbers of offspring (Tables 2 and 3) with the PRS in people without 
children; OR is derived as the exponential of the logistic regression Beta coefficient estimate, 
and represents the change in the odds of membership in the target group, defined by the 
exact numbers of children, with an increase of one standard deviation in PRS. In Figure 2, we 
show the distribution for the PRS of females and males by number of children. The boundaries 
of the box are the first and third quartiles, the horizontal line inside the box shows the median 
and "whiskers" above and below the box show the locations of the minimum and maximum. 
Across all categories of numbers of children, PRS is positively associated with the numbers 
offspring of females, that is, the higher the liability to schizophrenia, the more children they 
have (Table 2, Figure 2.A). In males, the effect was less consistent. Males with 1 or 2 children 
had lower schizophrenia PRS compared to those with no children. Indeed, schizophrenia PRS 
was associated with a relative absence of children born to fathers OR=0.96, 95%CI=[0.94, 
0.99], p=0.008, and OR=0.94, 95%CI=[0.92, 0.96], p=2.6x10-9, compared with PRS for 1 and 2 
children, respectively; see also first two lines of Table 2 and Figure 2.B). Moreover, there was 
a non-significant trend for schizophrenia PRS to be elevated in those with atypically large 
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numbers of offspring (5 or more). Comparing PRS for males with and without children, higher 
genetic liability to schizophrenia was associated with having no offspring in males (OR=0.96, 
95%CI=[0.94, 0.98], p=8.01x10-5). 
 
PRS x sex interaction 
We tested for an interaction effect between number of offspring, liability to schizophrenia 
(PRS) and sex using Poisson regression. The outcome variable was the number of children and 
the predictors were schizophrenia PRS, gender and an interaction term (schizophrenia PRS x 
gender). The interaction term was significant (B=-0.011, SE=0.004, p=0.009) over and above 
schizophrenia PRS (B=0.01, SE=0.003, p=8.8x10-5), gender (B=-0.021, SE=0.004, p=2.9x10-7) 
and age (B=0.015, SE=0.0003, p<10-16, respectively). The negative sign of the interaction term 
B coefficient indicates that the increase in the numbers of children in women with higher 
genetic loading to schizophrenia  was greater than that in men (in the UK Biobank women are 
oded as  a d e  a e oded as  a d as o e p o ou ed he  e o pa ed 
people with and without offspring (B=-0.08, SE=0.014, p=5.5x10-10) using logistic regression. 
The interaction of sex and PRS on number of offspring is depicted in Figure 3.  
 
Given the non linear relationship between PRS and fecundity in males (Table 3), we further 
explored the different patterns of relationship between genetic liability to schizophrenia and 
the total numbers of children of males and females. In Figure 4 we present these as ratios of 
the mean numbers of offspring born to males and females in 50%, 40%, ...., 10%, 5% and 1% 
percentiles of the schizophrenia PRS distribution to the total population mean. Relatively 
more children are born to females with higher PRS, and this increases towards the PRS 
extreme, plateauing at the 1%-ile. In males, a more complex pattern is observed, showing an 
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initial decrease in the relative fecundity as PRS increases followed by an increase and then at 
the extreme end of the distribution, a sharp decrease in relative fecundity.   
 
Discussion 
We sought to test the hypothesis that the burden of common risk alleles for schizophrenia is 
associated with reproductive advantage in subjects without schizophrenia, and that this 
might explain the persistence of common risk alleles in the population in the face of negative 
selection in those affected by schizophrenia.  Our findings suggest that at a population level, 
higher common variant genetic loading to schizophrenia is associated with a small 
reproductive advantage in females. The effect is not seen in males and there is evidence that 
those with the highest risk scores have fewer offspring. When males and females are 
considered together there is a net reproductive advantage associated with high PRS. 
However,  the effects of PRS are not sufficient to explain the persistence and allele 
frequencies of schizophrenia risk alleles in contemporary populations as they are small 
relative to the effects of schizophrenia itself on fecundity, which at a population level make a 
stronger impact.  
 
In considering the effects we have seen of PRS in unaffected individuals, we should bear in 
mind that schizophrenia liability is highly pleiotropic 22, that is, alleles that increase risk for 
schizophrenia also increase liability to other clinical, cognitive and behavioural traits, some of 
which may be associated with higher fecundity. For example, people with relatively poorer 
cognitive ability, a phenotype which is associated with higher schizophrenia polygenic risk 23, 
may be less motivated, have less opportunity, or less ability to control fertility. It is important 
to stress that links between fecundity on the one hand and behavioural and cognitive traits 
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on the other are highly dependent on the contemporary environmental context and that the 
present results apply to the UK population, one of the wealthiest populations in the world; 
whether they generalize globally and historically will depend on whether the effects are 
mediated by primarily by direct impacts on biology or, as we speculate above, an interplay 
between behavioural and personal traits and social, cultural, religious, and economic norms 
that are highly variable in history or in different societies. Therefore there is a need to test 
this hypothesis in different countries and cultures.  
 
It has previously been documented that the effect of schizophrenia on fecundity is more 
pronounced among males 2, 4, 24. Our population-based study demonstrates that higher 
genetic liability to schizophrenia is associated with childlessness in males.  We have also 
shown a significant statistical interaction between gender and genetic liability to 
schizophrenia. At the extreme on the liability scale of the PRS distribution (1%), males have 
fewer children than in other PRS %-tiles (see Figure 4). 
 
The sex related differences between number of children and schizophrenia liability is 
consistent with a family based study 25 in which the sisters of people with schizophrenia had 
a significantly increased number of children, while brothers of affected individuals had 
significantly fewer children. Our own and those findings are consistent with the idea of sexual 
selection 26, whereby number of offspring is substantially the result of female choice. Thus, 
the association between high PRS and childlessness in males (but not females) is consistent 
with female mating choices favouring males with characteristics related to lower 
schizophrenia liability (one might speculate for example better social cognition), whereas 
male mating choice is less relevant. However, other explanations are possible. Schizophrenia 
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liability may differentially influence the reproductive biological fitness of males and females, 
or behavioural and cognitive traits which would be selected against by both sexes may be 
differentially affected by schizophrenia liability in males and females.  
  
The strengths of our study are 1) the use of the largest European ancestry schizophrenia 
dataset to date to identify genetic risk loci and 2) the largest available genotyped population 
cohorts to generate schizophrenia PRS, and the ability to measure liability to schizophrenia 
directly at a molecular level. These allow us to test the hypothesis with extremely high power; 
including the ability to test the effects on males and females separately. Limitations are 1) our 
analysis is based upon common SNPs and the effects on fecundity of rare variants are not 
tested 2) we are unable to test mechanism, i.e. whether the genetic effects are mediated by 
behaviour or by reproductive biology 3) as noted, the conclusions are specific to place (UK) 
and time (participants largely of reproductive age in the latter half of the 20th century).  
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95%CI p R2* 
All sample 0.006 0.002 0.010 0.0017 8.4x10-5 
Males 0.0009 -0.005 0.007 0.745 3.9x10-6 
Females 0.011 0.006 0.016 7.1x10-5 0.0005 
 
* Estimated with the linear regression of the number of children of unaffected individuals 
on the PRS. 
 






children OR L95 U95 p R2 
0 13863 1 - - - - 
1 9926 1.071 1.044 1.099 2.1E-07 0.0010 
2 32732 1.031 1.011 1.052 0.0028 0.0002 
3 13044 1.042 1.017 1.068 0.0011 0.0003 
4 3379 1.085 1.044 1.128 3.3E-05 0.0012 
5 742 1.131 1.050 1.219 0.0012 0.0019 
6+ 317 1.196 1.069 1.336 0.0017 0.0034 
 
* as defined in column 1. 
OR is derived as the exponential of the logistic regression Beta coefficient estimate, and 
represents the change in the odds of membership in the target group, defined by the exact 
numbers of children with every increase of one standard deviation in PRS.
16 
 






children OR** L95 U95 p R2 
0 13787 1 - - - - 
1 8346 0.967 0.941 0.994 0.015 0.0002 
2 27945 0.942 0.923 0.962 2.19E-08 0.0008 
3 11089 0.982 0.957 1.007 0.159 4.2E-05 
4 3182 0.989 0.951 1.029 0.577 1.3E-07 
5 878 1.041 0.972 1.115 0.251 0.0003 
6+ 454 1.115 1.015 1.225 0.024 0.0015 
 
* as defined in column 1. 
** OR is derived as the exponential of the logistic regression Beta coefficient estimate, and 
represents the change in the odds of membership in the target group, defined by the exact 




Figure 1. The percentages of males and females with each category of number of children born to 






Figure 2. Distribution of schizophrenia PRS and numbers of children of females and males. 





Figure 3. Relationship between schizophrenia PRS of males and females and number of 
children. The effects of schizophrenia PRS were estimated by logistic regression, with 
schizophrenia PRS and sex as main effects, including the schizophrenia PRS x sex interaction 
term, adjusting for age.  
 
Legend: The figu e plots the o ditio al oeffi ie ts a gi al effe ts  of a ia les 
included in multiplicative interaction term in the regression model (i.e. the changes in the 





Figure 4. The mean number of children born to males and females  in the top %-tiles of the 
schizophrenia PRS distribution (x-axis) divided by the mean number of children in the whole 
sample. The numbers of children is truncated by 6+. 
 
 
Legend: A ratio greater than one (dashed horizontal line) means participants in the 
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1- The heritability (h2) of liability for schizophrenia that is explained by its polygenic risk 
score (PRS) has been estimated as 0.05153 (Pardiñas et al. 2018). At the moment 
that study was carried out, this result was based on the largest available training 
sample (34,241 cases and 45,604 controls; Schizophrenia Working Group of the 
Psychiatric Genomics Consortium 2014) and the largest available testing sample 
(5,220 cases and 18,823 controls; Pardiñas et al. 2018). The PRS used in the present 
study was produced by combining both samples, and thus this h2 value could be a 
slight underestimation. 
 
2- The lifetime prevalence of schizophrenia is 0.0072, which is the median of a review of 
188 independent studies (McGrath et al. 2008). According to the authors, the median 
is a more appropriate estimation of the central value than the mean due to the skewed 
distribution of prevalences reported by different studies. 
 
3- The ratio of fecundities of patients with schizophrenia to unaffected individuals is 0.35 
(Power et al. 2013). This figure might be an underestimation as it is based on a sample 
of people older than 40 years of age and does not account for the reduced life 
expectancy seen in schizophrenia (Laursen et al. 2014).  
 
4- In the present study, the linear regression of the number of children of unaffected 
individuals on the PRS gives r2=0.000084 with a 95% confidence interval r2=[0.000023 
– 0.000184]. The direction of effect shows that higher PRS leads to more children. 
 
5- In the present study, the mean and variance of number of children of unaffected 




1- Genetic variance for fecundity that is explained by the liability threshold model 
of schizophrenia: 
 
The liability threshold model is responsible for a fraction of the phenotypic variance for 
fecundity which can be calculated from the data above. The mean fecundity in the 
general population (i.e. affected and unaffected individuals) explained by the liability 
threshold model, considering only the reduction in fecundity caused by schizophrenia, 
is: 
 � = − . ∗ + . ∗ . = .  
 
After scaling for average fecundity=1, the phenotypic variance for fecundity in the 
general population, which is explained by the liability threshold model, is 
 � = [ − . ∗ 2 + . ∗ . 2 − �2]/�2 = .  
 
These calculations implicitly assume that the phenotypic variance is generated by the 
onset of schizophrenia (i.e. the disorder leads to a reduction in fecundity). Therefore, 
the heritability of schizophrenia equals the heritability of fecundity explained by 
schizophrenia. Consequently, the genetic variance for fecundity in the general 
population explained by variation in schizophrenia PRS under the liability threshold 
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model is the product of the phenotypic variance for fecundity and the heritability 
explained by PRS: 
 � _�� = . ∗ . = .  
 
2- Genetic variance for fecundity in unaffected individuals explained by variation 
in PRS: 
 
The squared correlation between fecundity and PRS is the proportion of the variation 
in fecundity that is explained by PRS. After scaling for average fecundity=1, we get: 
 � _ � = . ∗ .. 2 = .  
 
The largest source of error in all these calculations corresponds, by far, to the 
estimated r2. Using its 95% confidence interval we can get an approximation of 
plausible values for the genetic variance: 





If we consider that fecundity is a measure of fitness, genetic variance for fecundity is the 
expected change of fitness by selection in a single generation (Fisher 1930, Edwards 2014). 
Thus, the comparison of variances gives the relative magnitude of the two selective forces: 
 � _�� /� _ � = .   
 
A range can be approximated using the 95% confidence interval of � _ � : 
 � _�� /� _ � = [ .  −   . ]  
 
This ratio refers to the genetic variance explained by PRS in this study. Strictly, this cannot be 
extended to the whole genetic system affecting schizophrenia, unless we accept that the 
expected fertility of unaffected individuals is a linear function of the liability score of individuals 
for schizophrenia.  Thus, although the present study detects a selective force acting in favour 
of the persistence of schizophrenia risk alleles in the general population, its effect is offset by 
the removal of these alleles caused by the reduced fecundity of affected individuals. 
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